An Ancillary Pilot Trial Using Whole Genome Sequencing In Patients With Advance Refractory Cancer
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Advanced Cancer
Related studies linked through entity extraction aliases.
A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Phase 1, Open-label Trial to Determine Safety of OPB-51602 in Subjects With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Temsirolimus In Phase 0
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
A Phase 1 Study of LY2835219 In Participants With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY2584702 in Participants With Advanced Cancer
- Status
- TERMINATED
- Phase
- PHASE1
A Study of LY2228820 in Participants With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Surgical Procedures for Advanced Tumor Disease. A Prospective Study Evaluating Quality of Life
- Status
- COMPLETED
- Phase
- N/A
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Safety Study of FLP Injection to Treat Tumor Patients
- Status
- UNKNOWN
- Phase
- PHASE1
Emergency Department-Based Palliative Care for Advanced Cancer Patients
- Status
- COMPLETED
- Phase
- NA
Clinical Study Of PI3K/mTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Study of Pazopanib and Vorinostat in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
- Status
- COMPLETED
- Phase
- PHASE3
Paracetamol for Cancer Pain
- Status
- UNKNOWN
- Phase
- PHASE4
C14 Study in Oncology Patients With Advanced and/or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY2875358 in Participants With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY2090314 in Patients With Advanced or Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE3